Treatment of breast cancer by monoclonal antibodies

Herceptin - a monoclonal antibody for the treatment of breast cancer, was present in Vietnam . Drugs Herceptin (Photo: orbisdesign) According to Assoc. Prof. Nguyen Chan Hung - Chairman of Ho Chi Minh City Cancer Society, presented at the scientific conference on the morning of June 17, the research achievements in the past decade have determined that cancer is disease. of genes and the introduction of new therapies is 'targeted targeting therapy' with drugs targeting cancer cells that are overly expressed or overproduce a protein called HER-2, to slow down or stop the growth of these cells.

Herceptin was recognized in 1998 by the US Food and Drug Administration (FDA). In women with early-stage breast cancer, Herceptin reduces the risk of recurrence by 46% and helps prolong the life of cancer patients. Metastatic breast cancer.

The price of Herceptin is currently 13 million VND / bottle, the treatment cost is about 20,000 USD / year.